Opsens
Financials
Estimates*
| CAD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 32.8m | 29.5m | 34.5m | 35.3m | 48.3m | 65.7m | 93.9m |
| % growth | 36 % | (10 %) | 17 % | 2 % | 37 % | 36 % | 43 % |
| EBITDA | (<1m) | (<1m) | 1.7m | (8.9m) | (9.7m) | - | - |
| % EBITDA margin | (2 %) | - | 5 % | (25 %) | (20 %) | - | - |
| Profit | (2.0m) | (2.6m) | (1.2m) | (11.4m) | (12.4m) | - | - |
| % profit margin | (6 %) | (9 %) | (3 %) | (32 %) | (26 %) | - | - |
| EV / revenue | 2.0x | 2.4x | 7.4x | 8.8x | 4.6x | - | - |
| EV / EBITDA | -94.1x | -503.0x | 153.1x | -35.1x | -22.8x | - | - |
| R&D budget | 4.8m | 5.4m | 5.5m | 8.4m | 11.3m | - | - |
| R&D % of revenue | 15 % | 18 % | 16 % | 24 % | 23 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
| N/A | CAD3.8m | Post IPO Equity | |
| N/A | CAD1.8m | Post IPO Equity | |
| N/A | $8.5m | Post IPO Equity | |
| N/A | CAD5.2m | Post IPO Equity | |
$5.0m | Post IPO Equity | ||
| N/A | CAD15.0m | Post IPO Equity | |
| N/A | $8.0m | Post IPO Debt | |
| N/A | $28.8m | Post IPO Equity | |
* | N/A | $10.0m | Post IPO Equity |
* | N/A Valuation: CAD345m 9.8x EV/LTM Revenues -38.9x EV/LTM EBITDA | Acquisition | |
| Total Funding | - | ||
Recent News about Opsens
EditOpsens Inc. specializes in the development and manufacturing of fiber optic sensors, primarily serving the interventional cardiology, oil and gas, and industrial sectors. The company’s core product includes advanced fiber optic pressure guidewires used in Fractional Flow Reserve (FFR) procedures, which are critical in assessing the severity of coronary artery blockages. Opsens also offers a range of fiber optic measurement solutions tailored for industrial applications, providing precise pressure and temperature monitoring. The business model revolves around the sale of these high-precision sensors and related services, generating revenue through direct sales, partnerships, and long-term contracts with healthcare providers and industrial clients. Opsens operates in a niche market with high barriers to entry, leveraging its proprietary technology to maintain a competitive edge. The company is ISO 13485 and ISO 9001 certified, ensuring compliance with international quality standards.
Keywords: Fiber Optic Sensors, FFR, Interventional Cardiology, Pressure Guidewires, Oil and Gas, Industrial Applications, Temperature Monitoring, ISO 13485, ISO 9001, Proprietary Technology.